Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (181-190 of 868) with videos related to

Pageof 87
Sort By:
Cancers|December 10, 2021
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple MyelomaShih-Feng Cho, Lijie Xing, Kenneth C Anderson, et al.
Nature Reviews. Cancer|July 25, 2007
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targetsTeru Hideshima, Constantine Mitsiades, Giovanni Tonon, et al.
Blood Advances|January 9, 2024
Shrinking the divide: improving myeloma CART accessAjay K Nooka, Monique A Hartley-Brown, Kenneth C Anderson, et al.
Expert Opinion on Investigational Drugs|February 22, 2014
Daratumumab granted breakthrough drug statusJacob P Laubach, Yu-Tzu Tai, Paul G Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2003
Proteasome inhibitors disrupt the unfolded protein response in myeloma cellsAnn-Hwee Lee, Neal N Iwakoshi, Kenneth C Anderson, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Tanespimycin as antitumor therapyMeletios-Athanassios Dimopoulos, Constantine S Mitsiades, Kenneth C Anderson, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
From the bench to the bedside: emerging new treatments in multiple myelomaConstantine S Mitsiades, Patrick J Hayden, Kenneth C Anderson, et al.
Nature Clinical Practice. Oncology|November 3, 2006
Can thalidomide improve outcome in patients with multiple myeloma?Paul G Richardson, Constantine S Mitsiades, Nikhil C Munshi, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Proceedings of the Seventh International Workshop on Waldenström MacroglobulinemiaSteven P Treon, Christopher J Patterson, Nikhil C Munshi, et al.
Hematology. American Society of Hematology. Education Program|February 20, 2015
Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?Paul G Richardson, Jacob P Laubach, Nikhil C Munshi, et al.
Pageof 87

Showing results (181-190 of 868) with videos related to

Sort By:
Pageof 87
Cancers|December 10, 2021
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple MyelomaShih-Feng Cho, Lijie Xing, Kenneth C Anderson, et al.
Nature Reviews. Cancer|July 25, 2007
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targetsTeru Hideshima, Constantine Mitsiades, Giovanni Tonon, et al.
Blood Advances|January 9, 2024
Shrinking the divide: improving myeloma CART accessAjay K Nooka, Monique A Hartley-Brown, Kenneth C Anderson, et al.
Expert Opinion on Investigational Drugs|February 22, 2014
Daratumumab granted breakthrough drug statusJacob P Laubach, Yu-Tzu Tai, Paul G Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2003
Proteasome inhibitors disrupt the unfolded protein response in myeloma cellsAnn-Hwee Lee, Neal N Iwakoshi, Kenneth C Anderson, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Tanespimycin as antitumor therapyMeletios-Athanassios Dimopoulos, Constantine S Mitsiades, Kenneth C Anderson, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
From the bench to the bedside: emerging new treatments in multiple myelomaConstantine S Mitsiades, Patrick J Hayden, Kenneth C Anderson, et al.
Nature Clinical Practice. Oncology|November 3, 2006
Can thalidomide improve outcome in patients with multiple myeloma?Paul G Richardson, Constantine S Mitsiades, Nikhil C Munshi, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Proceedings of the Seventh International Workshop on Waldenström MacroglobulinemiaSteven P Treon, Christopher J Patterson, Nikhil C Munshi, et al.
Hematology. American Society of Hematology. Education Program|February 20, 2015
Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?Paul G Richardson, Jacob P Laubach, Nikhil C Munshi, et al.
Pageof 87